April 20, 2021
atHeart Medical has commenced operations and is initiating its U.S. IDE trial.
atHeart Medical announced today that it has commenced operations and is initiating its U.S. Investigational Device Exemption (IDE) trial Read more
Scott is a veteran regulatory affairs executive with a proven track record in successful global regulatory strategies.
Laurent is a global medtech executive with talent for turning research projects into commercially viable companies.